UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENTS OF INCOME - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Details
Sales, net (notes 1, 3, 9 and 11)	$ 42,178	$ 46,904	$ 41,998
Cost of goods sold	16,630	17,438	15,692
Gross profit	25,548	29,466	26,306
Sales and marketing	1,554	1,738	1,708
Research and development	486	483	454
General and administrative	9,800	9,613	5,447
Operating income	13,708	17,632	18,697
Dividend and interest income	112	254	217
Gains on investments	0	0	32
Royalty income (note 12)	20	6	76
Other, net	0	(8)	437
Income before provision for income taxes	13,840	17,884	19,459
Provision for income taxes (note 7)	3,042	3,157	904
Net income	$ 10,798	$ 14,727	$ 18,555
Earnings per common share (basic) (note 1)	$ 2.95	$ 3.96	$ 4.97
Earnings per common share (diluted) (note 1)	$ 2.94	$ 3.94	$ 4.95
Other comprehensive income (loss):
Foreign currency translation net of taxes of $0 in all periods	$ 1,502	$ 1,507	$ (2,949)
Total comprehensive income	$ 12,300	$ 16,234	$ 15,606